https://doi.org/10.55788/907949ef
Clinical comparisons of ablation lesion quality are currently lacking, although they can have implications for the efficacy and safety of the technologies employed. LGE-MRI can be a useful tool for the non-invasive assessment of ablation lesions [1]. Dr Till Althoff (University of Barcelona, Catalonia, Spain) presented an LGE-MRI lesion assessment of technologies including pulsed PFA(n=30), VHPSD (n=25), cryoballoon (n=40), and radiofrequency (n=43). All patients received an LGE-MRI assessment 3 months following the ablation procedure. LGE discontinuations of >3 mm were defined as gaps, while LGE covering >90% of the peri-antral circumference of ipsilateral pulmonary vein (PV) pairs were considered complete lesions.
The number of gaps per PV pair tended to be larger with PFA (median 1.5) compared with VHPSD (1.1; P=0.036), cryoballoon (1.1; P=0.012), and radiofrequency (1.2; P=0.091). Furthermore, the proportion of complete lesions was lowest with PFA (12%), followed by cryoballoon (24%), radiofrequency (26%) and VHPSD (40%). Relative to the PV circumference, the cumulative gap length was largest with PFA (median 36%) compared with VHPSD (15%), cryoballoon (19%), and radiofrequency (18%; P<0.001 for PFA vs all). Additionally, when assessing proportions of patients with a cumulative gap length of <10%, PFA was found to have the lowest number of continuous lesions (28%) compared with VHPSD (56%; P=0.003), cryoballoon (40%), and radiofrequency (45%; P=0.037). Finally, radiofrequency led to the lowest lesion width (mean 8.7 mm) compared with cryoballoon (13.3 mm; P<0.0001), VHPSD (10.9 mm), and PFA (12.7 mm; P<0.0001).
“VHPSD ablation resulted in the most continuous lesions and the highest proportion of complete PV-encircling lesions,” concluded Dr Althoff, “and VHPSD lesions were also significantly wider than conventional radiofrequency lesions,” while “PFA lesions cover relatively large areas as expected comparable to cryoballoon lesions, but these lesions seem to be more non-homogeneous.” However, longer term follow-up and higher sample sizes will be needed to inform clinical decisions.
- Althoff TF, et al. Head-to-head comparison of pulsed field ablation, very high power-short duration, cryoballoon and conventional radiofrequency ablation by LGE-MRI-based ablation lesion assessment. Atrial fibrillation: ablation 2. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« “Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation Next Article
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block »
« “Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation Next Article
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
Related Articles
May 31, 2022
Developments in imaging tools for AF
January 14, 2022
New developments in remote diagnostics and monitoring of AF
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com